Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I PK Study of Oral Tolvaptan in Healthy Male Subjects
NCT07166796Phase 1Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tolvaptan in hyponatremia (2 arms), sponsored by Otsuka Holdings. Primary endpoints: Single dose Tolvaptan plasma pharmacokinetics and metabolites and Multi dose Tolvaptan plasma pharmacokinetics and metabolites at Day 9. Started Oct 2006; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT07166796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07166796.